Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Drugs Made In America Acq...

    NASDAQ: DMAA · Real-Time Price · USD
    10.29
    0.02 (0.19%)
    At close: Oct 06, 2025, 11:04 AM

    Drugs Made In America Acquisition Ordinary Shares Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024
    Cash & Equivalents
    		 822.00 923.00 1.35K 2.1K 18.10
    Short-Term Investments
    		 n/a n/a 1.35K n/a n/a
    Long-Term Investments
    		 n/a 233.59M n/a n/a n/a
    Other Long-Term Assets
    		 235.16M -852.38K 545.83 424.04K 112.96
    Receivables
    		 n/a n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a n/a
    Other Current Assets
    		 48.9K n/a -4.99K n/a n/a
    Total Current Assets
    		 49.73K 71.02K 4.99 2.1K 78.10
    Property-Plant & Equipment
    		 n/a n/a n/a n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 235.16M 232.74M 545.83 424.04K 112.96
    Total Assets
    		 235.21M 232.81M 550.82 426.14K 191.06
    Account Payables
    		 147.45K 132.48K n/a n/a n/a
    Deferred Revenue
    		 n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 60.9K 662.32 552.01K 210.09
    Other Current Liabilities
    		 n/a n/a 56.06 38.98K 0.90
    Total Current Liabilities
    		 301.44K 347.37K 795.67 591K 210.99
    Long-Term Debt
    		 n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 6.9M 6.9M n/a n/a n/a
    Total Long-Term Liabilities
    		 6.9M 6.9M n/a n/a n/a
    Total Liabilities
    		 7.2M 7.25M 795.67 591K 210.99
    Total Debt
    		 n/a 60.9K 662.32 552.01K 210.09
    Book Value
    		 228M 225.56M -244.85 -164.86K -19.93
    Book Value Per Share
    		 6.80 23.47K -0.03 -19.23 -0.00
    Common Stock
    		 235.16M 232.74M 986.00 986.00 0.99
    Retained Earnings
    		 -6.46M -6.33M -279 -199.86K -54.93
    Comprehensive Income
    		 n/a n/a n/a n/a -0.00
    Shareholders Equity
    		 228M 225.56M -244 -164.86K -19.93
    Total Investments
    		 n/a 233.59M 1.35K n/a n/a

    Add to Watchlist